Back to search results

Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints

Abroad (travel likely)RecruitingPHASE4

Conditions

Posttraumatic Stress Disorder (PTSD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Birmingham VA Medical Center, Birmingham, AL, Birmingham, Alabama, United States

    Contact: Study coordinator (Lori Davis, MD) · 205-835-6962
    Contact: Study coordinator (Anchal Ghera, BS) · (205) 9338101

  • Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa, Alabama, United States

    Contact: Study coordinator (Lori Davis, MD) · 205-835-6962
    Contact: Study coordinator (Anchal Ghera, BS) · (205) 9338101

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington, United States

    Contact: Study coordinator (Rebekah J Rein, JD) · rebekah.rein@va.gov · 206-764-2711
    Contact: Study coordinator (Murray A Raskind, MD) · murray.raskind@va.gov · (206) 764-2702
    Murray A. Raskind, MD (Sub-investigator)
    Contact: Principal Investigator (Rebecca C. Hendrickson, MD PhD)
Study leads

  • Rebecca C. Hendrickson, MD PhD

    Principal Investigator

    VA Puget Sound Health Care System Seattle Division, Seattle, WA

View source on ClinicalTrials.gov(opens in a new tab)